WebDevang Thakor, PhD, JD President, Anioplex, LLC Strategic / scientific / business advisor and patent agent for startups, Global 500 corporations, VCs, and universities. Ex-USPTO primary examiner (>130 patents granted). Developed gene therapy and regenerative medicine technologies at Harvard Medical School, Kyoto University, and UCLA (>20 About Devang Thakor. Devang is a biopharma executive, scientist, and patent and corporate attorney. As the Vice President of Intellectual Property and Legal of a preclinical therapeutic mRNA startup, he is building the IP portfolio for an innovative cellular rejuvenation technology. Through a boutique consultancy, he also provides part-time non ...
Devang Gor, MD, MBA - LinkedIn
http://btb-newdrug.co.jp/en/index.html WebDec 11, 2024 · 今回の研修セミナーでは、Anioplex, LLC の経営者でありBiomedical Engineeringの博士号を持つ Devang Thakor氏が、シリコンバレーでのスタートアッ … dallas mavericks sch
BornGlobal TOWN HALL MEETING 16 e - astoriacg.com
WebDevang is a biopharma executive, scientist, and patent and corporate attorney. ... DEVANG THAKOR. Anioplex, LLC Founder / PresidentREAD MORE. READ MORE. YASUHISA … WebDevang Thakor, PhD, JD President, Anioplex, LLC Anioplex, LLC -Providing strategic, technical, and business advisory to startups, Global 500 corporations, VCs, and universities. Previously developed gene therapy and regenerative medicine technologies at Harvard Medical School, Kyoto University, and UCLA 瀬尾享氏ファイザー社 WebSep 21, 2010 · Devang K. Thakor, Yang D. Teng, ... We recently developed a negatively charged gene carrier (“anioplex”) based on pullulan-spermine, a conjugate prepared from a natural polysaccharide and polyamine. In rat mesenchymal stem cells (MSCs), anioplex-derived reporter gene activity was comparable to or exceeded that obtained using a … dallas mavericks schedule 2015 home games